FindTrial
Sign In

Evaluation of the impact of integrative Chinese and Western medicine individualized therapy on clinical outcomes in patients with heart failure

National Key research and development Program

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2100005283
Enrollment
Unknown
Registered
2021-09-08
Start date
2021-09-10
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Interventions

Conventional Therapy group:Conventional Therapy
Integrative therapy group:Integrative therapy

Sponsors

Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients aged 18-75 years who were admitted for the first time for heart failure and could complete follow-up were retrospectively included in the heart failure population attending the Department of Integrative Cardiology at China-Japan Friendship Hospital.

Exclusion criteria

Exclusion criteria: Patients with severe hepatic or renal abnormalities (transaminases elevated more than 3-fold or glomerular filtration rate <15 ml/min*1.73m2), severe diseases of the hematopoietic and endocrine systems, and those whose data collection was affected by mental language and other factors were excluded.

Design outcomes

Primary

MeasureTime frame
cardiovascular events;—

Countries

China

Contacts

Public ContactLin Li
lilinxcy@126.com84205041

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026